The Canada IV Equipment Market was valued at $285.81 Million in 2026 and projected to reach to $380.84 Million by 2031, representing a compound annual growth rate of 5.9%. Canada's IV Equipment Market is positioned for steady growth through 2031, driven by demographic pressures and healthcare system modernization.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada's demographic shift toward an older population is significantly increasing the need for IV equipment. Seniors require more frequent infusion therapies, chronic disease management, and palliative care, directly boosting market demand across healthcare facilities.
Canada's healthcare system is increasingly shifting toward home-based care models. This transition is creating substantial opportunities for portable and user-friendly IV equipment, as patients prefer receiving infusion therapies in home settings rather than hospitals.
Canadian provinces are investing heavily in modernizing healthcare infrastructure and upgrading medical equipment. These capital expenditures are driving adoption of advanced IV delivery systems across hospitals, clinics, and regional health authorities.
Health Canada's rigorous medical device approval process ensures high-quality IV equipment standards. This regulatory environment attracts premium product manufacturers and supports market growth through innovation and consumer confidence.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | NEEDLE-FREE CONNECTORS & EXTENSION SETS (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.1% from 2026 to 2031 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 17.79 (2026) |
| Revenue Forecast (Billions) | ~USD 23.92 (2031) |
| Segments Covered | Type, Application, End User |
3 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Long-term acute care hospital drug utilization,Inpatient rehabilitation facility drug utilization,Contract rehabilitation and ancillary services, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Pre- and post-automation services,Contract manufacturing and value engineering, |
| CONVATEC | United Kingdom | Public Company | Advanced wound care,Ostomy care,Continence and critical care, |
| IRADIMED CORPORATION | United States | Public Company | MRidium 3870/3860+ MRI-compatible infusion pump systems and disposables,3880 MRI-compatible patient vital signs monitoring system and accessories,3600 FMD1 ferromagnetic detection devices and remote alarm units, |
| POLY MEDICURE LTD. | India | Public Company | Infusion & Transfusion Therapy,Critical Care & Anesthesia/Respiratory,Dialysis & Renal Care, |
| CONMED CORPORATION | United States | Public Company | Sports medicine & soft tissue fixation (BioBrace, Y-Knot, TruShot, Agro Knotless),Powered large & small bone systems (Hall brand),General surgery – insufflation & smoke management (AirSeal, Buffalo Filter), |
| MALLINCKRODT PLC | Ireland | Private Company | Autoimmune and rare disease therapies,Neurology and rheumatology specialty products,Neonatal respiratory and critical care therapies, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (syringes, needles, catheters, sharps, specimen collection),Connected Care (infusion, medication management, automation, informatics),BioPharma Systems (prefillable drug delivery, CSTD, hazardous drug detection), |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV solutions, infusion systems, parenteral nutrition, dialysis-related therapies),Healthcare Systems & Technologies (smart beds, OR integration, monitoring, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services), |
| FRESENIUS SE & CO. KGAA | Germany | Public Company | Fresenius Helios (hospitals and outpatient care),IV generics and IV fluids,Clinical nutrition (enteral and parenteral), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion pumps and hardware,Infusion consumables and vascular access (Clave, Neutron, Tego, disinfection caps),IV solutions and diluents, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| MOOG, INC. | United States | Public Company | Military Aircraft,Commercial Aircraft,Space and Defense, |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular access & emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck clips, MiniLap, staplers, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS), |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | China | Public Company | Patient monitoring, anesthesia, ventilators, and life-support,Ultrasound and medical imaging (radiology, emergency, critical care),In-vitro diagnostics (CLIA, chemistry, hematology), |
| CARDINAL HEALTH | United States | Public Company | Pharmaceutical Distribution (Branded & Generic),Specialty Pharmaceutical & Manufacturer Services,Medical Products & Cardinal-Branded Devices, |
| AVANOS MEDICAL, INC. | United States | Public Company | Digestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA), |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products), |
| JMS CO., LTD. | United States | Public Company | U.S. Retail Coffee,U.S. Retail Pet Foods and Snacks,U.S. Retail Frozen Handheld and Spreads, |
Kindred Healthcare Inc. is a private United States-based healthcare company founded in 1985 with 64,200 employees. The company operates healthcare facilities and provides related medical services.
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ConvaTec is a United Kingdom-based public company founded in 1978. The company manufactures and distributes medical devices and healthcare products globally.
IraMed Corporation is a United States-based public company founded in 1992 with 166 employees. The company specializes in medical imaging and monitoring equipment.
Poly Medicure Ltd. is an Indian public company founded in 1995 with 3,082 employees. The company manufactures medical devices and healthcare products.
ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company manufactures and distributes surgical and medical devices.
Mallinckrodt PLC is an Ireland-based private company with a history dating to 1867 and 2,687 employees. The company operates in the pharmaceutical and medical device sectors.
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. The company is a global leader in medical technology, manufacturing diagnostic and healthcare devices.
Baxter is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures medical devices, pharmaceuticals, and healthcare solutions.
Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. The company is a global healthcare company providing dialysis, infusion therapy, and hospital products.
ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures critical care medical devices and infusion therapy products.
Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices and healthcare products globally.
Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care and surgical applications.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company manufactures medical devices and diagnostic equipment.
Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. The company is a global healthcare services and products company serving hospitals and healthcare providers.
Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company manufactures and distributes medical devices for healthcare applications.
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures medical devices, pharmaceuticals, and healthcare products.
JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company manufactures medical devices and healthcare products.
Canada's IV Equipment Market is estimated at $285.81 million in 2026, with projected growth to $380.84 million by 2031.
Canada's IV Equipment Market is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2031.
Key drivers include Canada's aging population, increased prevalence of chronic diseases, government healthcare investments, and rising demand for advanced infusion therapies and safety-engineered devices.
Smart infusion pumps, safety-engineered IV devices, and connected IV solutions are experiencing accelerated adoption in Canada due to regulatory requirements and digital health integration initiatives.
Canada represents a significant segment of the North American IV Equipment Market, with steady growth driven by its robust healthcare infrastructure and emphasis on patient safety standards.
This study relied heavily on both primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and company SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IV equipment market. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the IV equipment market. The primary demand-side sources include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.
Breakdown of Primary Interviews:
A breakdown of the primary respondents for the IV equipment market (supply side) is provided below:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion,
Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
In this report, the global IV equipment market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the IV equipment business were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.
To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involved the following steps:
Global IV Equipment Market Size: Top-down & Bottom-up Approach

After arriving at the overall market size through the market size estimation process explained above, the global IV equipment market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the IV equipment market was validated using both top-down and bottom-up approaches.
IV equipment refers to the complete set of medical devices, accessories, and consumables used to deliver fluids, medications, nutrients, and blood products directly into a patient’s bloodstream through intravenous (IV) access. It includes infusion pumps, IV administration sets, catheters and cannulas, needle-free connectors, extension sets, securement devices, and related safety components designed to ensure accurate, controlled, and sterile delivery of therapies in hospitals, outpatient centers, and home care settings. IV equipment is essential for hydration, drug infusion, chemotherapy, parenteral nutrition, anesthesia, critical care, and emergency treatment.
Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the present global IV equipment market report:
Full forecast, segment splits, and company analysis for all IV Equipment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report